Nkarta, Inc. (NKTX)

↓ Download CSV

CIK 0001787400 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Nkarta, Inc. reported revenue of $0. The company ran a net loss. It held $404.21M in total assets against $91.88M in total liabilities.

Key ratios (FY2025)

-33.3%
Return on equity
Metric (FY)20252024202320222021202020192018
Revenue$0$0$115.0K
Operating Income-$122.00M-$128.19M-$131.65M-$118.95M-$86.43M-$51.51M-$22.35M
Net Income-$104.08M-$108.79M-$117.50M-$113.84M-$86.08M-$91.36M-$21.08M
EPS (Diluted)$-1.41$-1.60$-2.40$-2.61$-2.62
Total Assets$404.21M$501.20M$378.88M$472.94M$273.90M$337.65M$48.41M
Total Liabilities$91.88M$93.23M$105.60M$100.73M$22.94M$16.43M$14.08M
Shareholders' Equity$312.32M$407.98M$273.29M$372.21M$250.97M$321.22M-$25.48M-$5.40M
Cash & Equivalents$39.63M$27.87M$31.04M$37.49M$60.82M$96.69M$20.61M
Operating Cash Flow-$88.70M-$99.70M-$86.16M-$57.00M-$67.93M-$43.51M-$18.37M
Capital Expenditures$1.21M$4.41M$28.15M$47.11M$5.03M$7.51M$1.93M
Shares Outstanding71.08M70.65M49.18M48.88M32.97M32.63M1.60M
Dividends Per Share$0.00$0.00$0.00